Synthesis and Evaluation of Novel 3-(5-phenyl-3H-1,2,4] Dithiazol-3-yl)-4H-chromen-4-one Derivatives for Antimicrobial Activity

Authors

  • Ramandeep Kaur Department of Pharmaceutical Sciences, Guru Nanak Dev University, Amritsar-143001, India

DOI:

https://doi.org/10.37591/(rrjops).v4i2.928

Abstract

 

A novel 3-(5-phenyl-3H-1,2,4] dithiazol-3-yl)-4H-chromen-4-one derivatives 16a–d were synthesized and evaluated for antimicrobial activity, i.e., antifungal and antibacterial activities. The in vitro antifungal evaluation revealed that the compounds 16d showed maximum activity against Geotrichum candidum. The compound 16a showed significantly good activity against Candidum tropicalis. The compounds 16b and 16c did not show any significant antifungal activity. The in vitro antibacterial activity showed no significant results against different bacterial strains. It was finally concluded that all the compounds show antifungal activity only.

 

Keywords: Antibacterial, antifungal, antimicrobial

 

Downloads

Published

2021-01-13

Issue

Vol. 4 No. 2 (2013)

Section

Research Article

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  •  I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

4. ________________

 

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.